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Intracytoplasmic Sperm Injection Outcome 
Using Ejaculated Sperm and Retrieved Sperm in 
Azoospermic Men 
Tahira Naru,1 M Nasir Sulaiman,2 Atiya Kidwai,3 M Hammad Ather,2 Sana Waqar,4 
Saadia Virk,1 Javed H Rizvi1
Introduction: We aimed to determine pregnancy and miscarriage rates 
following intracytoplasmic sperm injection (ICSI) cycles using retrieved 
epididymal and testicular sperm in azoospermic men and ejaculated sperm in 
oligospermic and normospermic men. 
Materials and Methods: This retrospective study was carried out on 517 
couples who underwent ICSI. They included 96 couples with azoospermia 
and 421 with oligospermia or normal sperm count in the male partner. Of the 
men with azoospermia, 69 underwent percutaneous epididymal aspiration 
(PESA) and 47 underwent testicular sperm extraction (TESE). In the 421 
men with oligospermia or normal sperm count, ejaculated sperm was used 
for ICSI. The differences in the outcomes of ICSI using PESA or TESE and 
ejaculated sperm were evaluated. The main outcome measures were pregnancy 
and miscarriage rates.  
Results: No significant differences were seen in pregnancy and miscarriage 
rates with surgically retrieved and ejaculated sperm. The pregnancy rates 
(including frozen embryo transfer) were 43.5%, 36.2%, and 41.4% in 
couples with PESA, TESE, and ejaculated sperm, respectively (P = .93). The 
miscarriage rates were 16.7%, 23.5%, and 12.1%, respectively (P = .37). 
Conclusion: Intracytoplasmic sperm injection in combination with PESA 
and TESE is an effective method and can successfully be performed to treat 
men with azoospermia. The outcomes with these procedures are comparable 
to ICSI using ejaculated sperm.
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INTRODUCTION
Azoospermia, the absence of 
sperm in ejaculated semen, is the 
most severe form of male-factor 
infertility. It affects approximately 
5% of all men and accounts for one-
third of all male-factor infertility 
cases.(1) Prior to the availability of 
assisted reproductive techniques, 
the use of donor sperm was the 
only option offering the realistic 
chance of conception for couples 
affected by azoospermia or severe 
oligospermia. Over the past 2 
decades, the availability of surgical 
sperm retrieval methods and 
introduction of intracytoplasmic 
injection (ICSI) in assisted 
reproduction have been landmark 
achievements in the treatment of 
severe male-factor infertility.(2,3)  
Several surgical techniques have 
been used to retrieve sperm for 
assisted reproduction, including 
microsurgical epididymal 
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aspiration, percutaneous epididymal aspiration 
(PESA), testicular sperm extraction (TESE), 
and testicular sperm aspiration.(4) Percutaneous 
epididymal sperm aspiration, a less invasive 
procedure for retrieval of epididymal 
spermatozoa, can be performed under local 
anesthesia.(5) If PESA fails, then TESE can also be 
attempted, as it has been shown to be an efficient 
minimally invasive method.(6) It has been shown 
that hormone level and testicular histology are 
unable to predict which men with azoospermia 
will have sperm retrieved by PESA or TESE.(7) 
There are few published studies comparing the 
results of ICSI between epididymal or testicular 
retrieved sperm and ejaculated sperm.(8,9) The aim 
of this study was to compare the outcomes of 
ICSI cycles using PESA or TESE in azoospermic 
men with those using ejaculated sperm in 
oligospermic and normospermic men. 
MATERIALS AND METHODS
Patients
This retrospective study was carried out in a 
private center for assisted reproduction from 
January 2004 to December 2006. The cohort 
included 517 infertile couples treated by ICSI. 
These included 96 couples with azoospermia and 
421 with oligospermia or normal sperm count in 
the male partner, according to the World Health 
Organization criteria.(10) A total of 116 successful 
retrieval procedures were performed in the 96 
azoospermic men, 69 of which were PESA and 
47 were TESE procedures. In the 421 men with 
oligospermia or normal sperm count, 437 ICSI 
cycles were performed using ejaculated sperm. 
Procedures
All men presenting with infertility who had 
azoospermia on at least 2 semen analyses 
were further evaluated. The patients had a 
comprehensive history taken followed by 
physical examination including inguinoscrotal 
examination. Testicular volume was determined 
by a Prader orchidometer and the status of the 
epididymis and the presence or absence of vas 
deferens was noted. Hormone levels including 
follicle-stimulating hormone were evaluated in 
all azoospermic men. Other tests for hormones 
such as serum levels of testosterone, luteinizing 
hormone, and prolactin were done more 
selectively as dictated clinically. If there was 
suspicion of obstructive azoospermia, further 
evaluation, including transrectal ultrasonography, 
was performed to rule out ejaculatory duct 
obstruction. All men with azoospermia were 
counseled for need of further workup including 
genetic testing. Data, however, is not included 
in the present analysis due to its lack of direct 
bearing on the objectives of the study.
Patients with a testicular volume of 15 mL or 
greater underwent a diagnostic PESA. If no 
spermatozoon was found, TESE under the same 
local or general anesthesia was performed. On 
confirmation of the spermatozoa on PESA or 
TESE, the couple was counseled to undergo 
therapeutic PESA or TESE on the day of ovum 
pickup. Cycle treatment with controlled ovarian 
hyperstimulation was started 6 to 8 weeks after 
the diagnostic procedure. 
Percutaneous epididymal aspiration was 
performed on an outpatient basis under local 
or general anesthesia. Negative pressure was 
utilized with a 27.5-gauge insulin syringe 
prefilled with 0.1 mL of 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid-buffer human tubal 
fluid. In order to aspirate the maximum quantity 
of material possible, the needle was directed 
into the most prominent part of the epididymal 
head. The sample was further divided using 2 
needles of 1 mL (29 gauge) and examined under 
a magnification of × 400 in the microscope 
for the presence of sperm cells. Discontinuous 
density gradients (isolation) were used in all cases 
to separate spermatozoa and spermatids. The 
gradient scales and compositions applied were 3 
minidensity gradients containing volumes of only 
0.3 mL to 0.5 mL of different density gradient 
materials (50%, 70%, and 85% isotonic solutions). 
After centrifugation (300 rpm), another medium 
bath was made up (0.3 mL) into a pellet-
containing spermatozoa. All metaphase II oocytes 
were injected for ICSI according to the standard 
protocols.
Ovarian stimulation was performed using long 
protocol of standard technique of gonadotropin-
releasing hormone agonist downregulation and 
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controlled stimulation with recombinant follicle-
stimulating hormone. Cycle was monitored by 
ultrasonography and estradiol levels from the 
7th day of stimulation. Once the follicular sizes 
exceeded 1.7 × 1.7 cm, ovum pickup under 
general anesthesia and ultrasonographic control 
was conducted 36 hours after injection of human 
chorionic gonadotropin. The total number of 
oocytes retrieved in a cycle was 10 or more. On 
the same day, sperm retrieval was performed by 
PESA or TESE. After retrieval and preparation 
of an adequate number of sperm, ICSI was 
performed on mature eggs. Fertilization was 
confirmed 24 hours later and embryo transfer  
was performed on day 3 of ovum pickup. The 
number of embryos transferred was 2 to 3 per 
cycle. Only high-quality embryos (grades 1  
and 2) were transferred. If more than 3 good 
embryos were left after embryo transfer, they 
were cryopreserved, thawed, and transferred in 
frozen embryo transfer cycle.
Statistical Analyses
Data were analyzed using the SPSS software 
(Statistical Package for the Social Sciences, version 
14.0, SPSS Inc, Chicago, Ill, USA). Results were 
expressed as mean ± standard deviation for 
continuous variables. The independent sample 
t test was used to compare the mean differences 
in testicular volume and ages of each partner 
between PESA and TESE groups. The chi-square 
test was used to compare presence of vas deferens, 
pregnancy rate, and miscarriage rate between the 
groups of couples. A P value less than .05 was 
considered significant.
RESULTS
The mean ages of men in the PESA and TESE 
groups were 36 ± 8 years and 37 ± 7 years, 
respectively. While the mean ages of the male and 
female partners in the PESA and TESE groups 
were not significantly different (Table 1),  
those of the couples with normal sperm count 
or oligospermia in the male partner were 
slightly higher (31 ± 5 years and 41 ± 6 years, 
respectively). The mean testicular volume was not 
significantly different between the two groups of 
PESA and TESE as shown in Table 1.
The average fertilization rate in our private center 
is 80% and the average implantation rates for 
ICSIs with PESA, TESE, and ejaculated sperm 
are 20%, 18.8%, and 18.2%, respectively. The 
pregnancy rates after PESA-ICSI and TESE-ICSI 
were 43.5% and 36.2%, respectively. These were 
comparable with the pregnancy rate achieved 
with ejaculated sperm (41.4%; P = .93). There 
was no significant difference in miscarriage rates 
between the three groups of couples (Table 2). 
Overall, 38 normal deliveries yielded birth of 
54 babies in the PESA/TESE group and 159 
normal deliveries led to birth of 226 babies in 
the ejaculated sperm group. The rates of multiple 
pregnancies were not significantly different 
between the two groups with PESA/TESE and 
Parameters PESA TESE Ejaculated Sperm P
Treatment cycles† 69 47 437 …
Number of couples 53 43 421 …
Frozen embryo transfer cycles 18 3 65 …
Pregnancy 30 (43.5) 17 (36.2) 181 (41.4) 0.93
Miscarriage‡   5 (16.7)   4 (23.5)   22 (12.1) 0.37
Table 2. Pregnancy and Miscarriage Rates After Intracytoplasmic Sperm Injection Using Sperm Supplied by Percutaneous Epididymal 
Aspiration (PESA), Testicular Sperm Extraction (TESE), and Ejacutaion*
*Ellipses indicate not applicable. Values in parentheses are percents.
†Treatment cycles included transvaginal ovum pickup plus embryo transfer.
‡Percentages are calculated with the number of pregnancies as denominator.
Characteristics PESA TESE P
Number of couples 53 43 …
Mean age, y
Male partner  36 ± 8  37 ± 7 .52
Female partner  29 ± 6  29 ± 6 .99
Testicular volume, mL  15.07 ± .71  15.02 ± .77 .74
Presence of vas deferens 34 (64.1) 27 (62.8) .89
Number of cycles treated 69 47 …
Table 1. Characteristics in Couples With Azoospermic Male-
Factor Infectility Who Underwent Percutaneous Epididymal 
Aspiration (PESA) and Testicular Sperm Extraction (TESE)*
*Ellipses indicate not applicable. Values in parentheses are percents.
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ejaculated sperm (Table 3).
The total number of women who got pregnant 
after PESA/TESE cycles in all age groups was 
47/116 (40.5%). A higher pregnancy rate was 
achieved among female partners with an age 
between 20 and 29 years, and those older than 35 
years had a significantly lower conception rate. 
The same results were found in the group of the 
couples with ejaculated sperm (Table 4).
DISCUSSION
The approach to azoospermic patients has 
changed significantly with the introduction 
of sperm retrieval techniques and assisted 
reproduction, especially the ICSI. In addition 
to improving pregnancy rates using sperm 
from ejaculated semen, ICSI has opened new 
possibilities for achieving pregnancy with sperm 
retrieved from the epididymes or testes which 
have been performed for more than 10 years. 
Satisfactory results have been achieved in various 
studies using these techniques.(2,3,11)
The results of this study showed that there was 
no significant difference in the treatment outcome 
following ICSI using surgically retrieved sperm 
(PESA/TESE) and ejaculated sperm. Pregnancy 
rates of 43.5% and 36.2% from PESA-ICSI and 
TESE-ICSI were similar to that of 41.4% found 
in the cases of ICSI with ejaculated sperm. The 
miscarriage rate was 16.7% and 23.5% in PESA 
and TESE, whereas in ICSI cycles with ejaculated 
sperm the miscarriage rate was 12.0% (P = .37).  
There was also no significant difference in 
miscarriage rates between PESA and TESE 
groups (P = .85). Other researchers have reported 
that the use of testicular sperm leads to a higher 
spontaneous miscarriage rate.(12,13) On the other 
hand, Aboulghar and colleagues and other authors 
did not find any significant difference between the 
treatment results following ICSI with ejaculated 
sperm and with epididymal sperm.(8,9) A recent 
meta-analysis of surgical sperm retrieved in 
azoospermic patients, however, concluded that 
sperm origin does not affect cycle outcome.(14) 
Age of the female partner, however, has been 
shown to exert substantial influence on the 
success of ICSI treatment. In line with our 
findings, Devroey and associates found that the 
delivery rate in women younger than 40 years was 
25.4%, while in those older than 40 years, it was 
8.5%.(15) Silber and colleagues also reported low 
delivery rate in women aged more than 37 years.
(16) Of the other factors considered for prediction 
of successful ICSI are hormone profile, testicular 
volume, and histopathology findings; few studies 
have reported that these parameters are unable 
to predict which procedure would be successful 
in azoospermic men.(7,17) In our study, the main 
emphasis was on genital examination to measure 
the testicular volume with orchidometer, the 
status of epididymis, and presence or absence of 
the vas deferens. We used PESA procedure as a 
diagnostic technique in all azoospermic men. It is 
Parameters PESA TESE Ejaculated Sperm P
Successful Delivery 25 13 159 …
Twins   7 (28.0)   5 (38.5)   43 (27.0) 0.68
Triplets 1 (4.0) 1 (7.7) 12 (7.5) 0.81
Multiple pregnancy rate, % 32.0 46.2 34.6 0.66
Table 3. Multiple Pregnancies Following Intracytoplasmic Sperm Injection Using Sperm Supplied by Percutaneous Epididymal 
Aspiration (PESA), Testicular Sperm Extraction (TESE), and Ejaculation*
*Ellipses indicate not applicable. Values in parentheses are percents.
PESA/TESE Ejaculated sperm
Age, y Patients Pregnancy (%) Patients Pregnancy (%)
20 to 29 52 29 (55.8) 161 81 (50.3)
30 to 35 28 15 (53.6) 127 63 (49.6)
> 35 16   3 (18.7) 133 37 (27.8)
Table 4. Pregnancy Rates According to Age Groups of Female Partners*
*Frozen embryo transfer cycles are included in the rates. PESA indicates percutaneous epididymal aspiration and TESE, testicular sperm 
extraction.
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desirable to perform a diagnostic PESA procedure 
before planning an ICSI and committing resources 
to ovulation induction treatment and to select 
the patients with greater chance of successful 
retrieval. This facilitates counseling of couples 
and has financial and medicolegal benefits, as well. 
As pregnancy rates are acceptable in men with 
azoospermia, ICSI associated with sperm retrieval 
techniques should be employed in assisted 
reproduction centers. It allows good pregnancy 
rates in relation to patients with azoospermia. On 
the basis of our results, PESA should be the first 
option offered to patients. If spermatozoa cannot 
be recovered, TESE can be offered.
CONCLUSION
In conclusion, our study confirms that minimally 
invasive techniques of PESA and TESE can be 
successfully performed to retrieve sperm for ICSI 
in the treatment of azoospermic men. It should be 
emphasized that ICSI for the treatment of severe 
male-factor infertility is especially important in 
our culture, because the use of donor spermatozoa 
is forbidden. The result of this study indicates 
that treatment outcomes of PESA/TESE-ICSI 
including frozen embryo transfer cycles compare 
favorably with that of ICSI using ejaculated 
sperm. 
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